A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
New England Journal of MedicinePublished 24 April 1997Open access
Mary Sano, Christopher Ernesto, Ronald G. Thomas, Melville R. Klauber, Kimberly Schafer, Michael Grundman
Citations2,371
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In patients with moderately severe impairment from Alzheimer's disease, treatment with selegiline or alpha-tocopherol slows the progression of disease.
Abstract
In patients with moderately severe impairment from Alzheimer's disease, treatment with selegiline or alpha-tocopherol slows the progression of disease.
Keywords
Medicine
Journal of Psychiatric Research“Mini-mental state”
86,858 Citations1975Marshal F. Folstein, Susan E. Folstein +1 more
A simplified, scored form of the cognitive mental status examination, the “Mini-Mental State” (MMS) which includes eleven questions, requires only 5-10 min to administer, and is therefore practical to use serially and routinely.
Scandinavian Journal of StatisticsA Simple Sequentially Rejective Multiple Test Procedure
21,827 Citations1979Sture Holm
American Journal of PsychiatryA new rating scale for Alzheimer's disease
4,123 Citations1984Wilma G. Rosen, Richard C. Mohs +1 more
A new rating instrument, the Alzheimer's Disease Assessment Scale, was designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic of persons with Alzheimer's disease.
The British Journal of PsychiatryThe Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects
4,123 Citations1968G. Blessed, B. E. Tomlinson +1 more
The expectation of mental disorder shows a steep increase with advancing chronological age, and beyond 75 years a large part of this increase is accounted for by disorders associated with degenerative changes in the central nervous system for which the authors lack remedies at the present time.
Proceedings of the National Academy of SciencesExcess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
1,295 Citations1991Charles D. Smith, John M. Carney +5 more
It is concluded that protein oxidation products accumulate in the brain and that oxidation-vulnerable enzyme activities decrease with aging in the same regional pattern (frontal more affected than occipital) and that AD may represent a specific brain vulnerability to age-related oxidation.
New England Journal of MedicineEffects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
1,216 Citations1993
Deprenyl but not tocopherol delays the onset of disability associated with early, otherwise untreated Parkinson's disease and the action of deprenyl that accounts for its beneficial effects remains unclear.
JAMAA 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease
971 Citations1994Margaret J. Knapp
Tacrine produced statistically significant, dose-related improvements on objective performance-based tests, clinician- and caregiver-rated global evaluations, and measures of quality of life.
Antioxidants and Redox SignalingThe Free Radical Theory of Aging
916 Citations2003Denham Harman
The extensive studies based on this possibility hold promise that the ALE-B can be extended to >85 years and the maximum life span increased.
Trends in NeurosciencesOxygen radicals and the nervous system
820 Citations1985Barry Halliwell, John M.C. Gutteridge
The brain has a high oxygen consumption and is rich in oxidizable substrates, mainly catecholamines and unsaturated lipids, and the possible use of anti-oxidants in treating degenerative diseases of the nervous system and the consequences of ischaemia is explained.
Biochemical and Biophysical Research CommunicationsVitamin E protects nerve cells from amyloid βprotein toxicity
582 Citations1992Christian Behl, John B. Davis +2 more
It is shown here that ABP and an internal fragment encompassing residues 25 to 35 (beta 25-35) are cytotoxic to a clone of PC12 cells at concentrations above 1 x 10(-9)M and to several other cell lines at higher concentrations.
JAMAA controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group
543 Citations1992Martin Farlow
American Journal of PsychiatryThe Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease
430 Citations1995Pierre N. Tariot, James Mack +8 more
The Behavior Rating Scale for Dementia provides a standardized, reliable measure that can be administered to caregivers of demented subjects and is available for general use in assessing a wide range of psychopathology in dementia.
Controlled Clinical TrialsDesigns for group sequential tests
351 Citations1984Thomas R. Fleming, David P. Harrington +1 more
An alternative procedure is proposed that offers a good opportunity for early termination when initial results are extreme, while essentially maintaining the power provided by the procedure that applies when the corresponding test statistic is computed only at the predetermined time of final analysis.
American Journal of Clinical NutritionAntioxidants and immune response in aged persons: overview of present evidence
299 Citations1995SN Meydani, Dayong Wu +2 more
The effects of antioxidants, vitamin E, beta-carotene, and glutathione on the immune response of aged persons is summarized and the underlying mechanisms for the antioxidant nutrients' effects as well as their health implications for aged persons are discussed.
Brain ResearchProtective effect of α-tocopherol on ischemic neuronal damage in the gerbil hippocampus
179 Citations1990Hideaki Hara, Hiroyuki Kato +1 more
The results suggest that free radical scavenging action of alpha-tocopherol played an important role in preventing the neuronal death in the gerbil.
JAMAA 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group
167 Citations1994M. J. Knapp
Tacrine produced statistically significant, dose-related improvements on objective performance-based tests, clinician- and caregiver-rated global evaluations, and measures of quality of life.
Journal of GerontologyAssessing Patient Dependence in Alzheimer's Disease
164 Citations1994Yaakov Stern, Steven M. Albert +7 more
Dependence is a distinct, measurable component of dementing disease and should be considered an important outcome in studies of AD.
Acta Neurologica ScandinavicaDeprenyl (selegiline): the history of its development and pharmacological action
156 Citations1983J. Knoll
Deprenyl inhibits MAO‐B selectively in different animal species and in man and is able to block MAO-B activity in the brain selectively in vivo in four species with s.c. administration.
NeurologyA 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease
151 Citations1996L. J. Thal, Angelico Carta +10 more
The study suggests that a subgroup of AD patients aged 65 or younger may benefit from treatment with ALCAR whereas older individuals might do more poorly, however, these preliminary findings are based on post hoc analyses.
European NeurologyEffects of a MAO-B Inhibitor in the Treatment of Alzheimer Disease
150 Citations2008Arduino A. Mangoni, M. P. Grassi +6 more
L-deprenyl would seem to be a useful and reliable tool for the treatment of DAT patients in an attempt to improve their cognitive functions and reduce behavioral alterations, without frequent or severe side effects.
American Journal of PsychiatryTrial of d-alpha-tocopherol in Huntington's disease
136 Citations1995Carol E. Peyser, Marshal F. Folstein +8 more
Antioxidant therapy may slow the rate of motor decline early in the course of Huntington's disease.
Psychiatric Clinics of North AmericaPathology of Alzheimer's Disease
132 Citations1991John P. Blass, Brian Ko +1 more
At the neurotransmitter level, Alzheimer's disease involves not only loss of cholinergic cells but of serotonergic and other neurotransmitter systems as well and damage to mitochondria may play an important role in precipitating the cellular pathophysiology.
BiometricsWhat Price Kaplan-Meier?
128 Citations1983Rupert G. Miller
The asymptotic efficiency of the Kaplan-Meier product-limit estimator, relative to the maximum likelihood estimator of a parametric survival function, is examined under a random-censoring model.
Journal of NeurochemistryPostischemic Cerebral Lipid Peroxidation In Vitro: Modification by Dietary Vitamin E
126 Citations1985Shin�ichi Yoshida, Raul Busto +3 more
The modification by VE of reoxygenation‐induced lipid peroxidation suggests free radical mediation in rats and propagates peroxidative reactions within esterified polyunsaturated FAs.
Journal of the American College of NutritionEpidemiologic studies of antioxidants and cancer in humans.
116 Citations1995Elaine W. Flagg, Ralph J. Coates +1 more
The data concerning carotenoids and lung cancer risk were most consistent, with strong associations that tended to follow a dose-response pattern, and more definite conclusions about the benefits of antioxidants in cancer prevention will be derived from on-going intervention trials.
Clinical NeuropharmacologyNeuropsychological Effects of L-Deprenyl in Alzheimerʼs Type Dementia
115 Citations1990Gian Luigi Piccinin, Giancarlo Finali +1 more
The results of the study show the higher and statistically significant effects of L-deprenyl on memory and attention that seem to be due to an improved function of the monoaminergic systems involved in the process of neuronal degeneration.
Critical Reviews in Food Science and NutritionCritical assessment of the epidemiological data concerning the impact of antioxidant nutrients on cancer and cardiovascular disease
88 Citations1995Lawrence J. Machlin
A number of studies where dietary and supplementary vitamin E were clearly differentiated, a reduced risk of certain cancers or cardiovascular disease from supplemental vitamin E but not from dietary vitamin E was demonstrated, providing strong presumptive evidence that high intakes of vitamin E per se provide a health benefit.
Archives of NeurologyInterrater Reliability of Extrapyramidal Signs in a Group Assessed for Dementia
80 Citations1991Marcus Richards, Karen Marder +4 more
Good interrater reliability was found for the presence or absence of extrapyramidal signs, although agreement over the presence of some signs was reduced when distinctions between normality and slight departures from normality were required.
Journal of NeurotraumaPretreatment with Alpha Tocopherol Enhances Neurologic Recovery After Experimental Spinal Cord Compression Injury
72 Citations1988Douglas K. Anderson, Thomas Waters +1 more
The results strongly suggest that lipid peroxidation and/or hydrolysis is primarily involved in the genesis of posttraumatic paralysis and that alpha tocopherol exerts its protection of injured spinal cord tissue, at least in part, by its antioxidant and/ or antilipolytic activity.
Alzheimer Disease & Associated DisordersRationale and Design of a Multicenter Study of Selegiline and α-Tocopherol in the Treatment of Alzheimer Disease Using Novel Clinical Outcomes
62 Citations1996Mary Sano, Christopher Ernesto +7 more
A randomized double-blind, placebo-controlled, 2 x 2 factorial, parallel group design to test two drugs for the treatment of AD to determine if these agents reduce the time to reach any endpoint.
Journal of the American Geriatrics SocietyL‐Deprenyl in the Treatment of Mild Dementia of the Alzheimer Type: Results of a 15–Month Trial
50 Citations1993W. J. Burke, William H. Roccaforte +4 more
Cognitive and behavioral effects of L‐deprenyl in persons with mild dementia of the Alzheimer type (DAT) over a 15‐month period are examined.